Skip to content
mirabegron

Structure via PubChem · Public domain (PubChem)

EntityQ3702534· pop 21· linked from 597 articles

mirabegron

Sign in to save

Also known as Betmiga®, Myrbetriq®, YM-178

Mirabegron, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. Its benefits are similar to antimuscarinic medication such as solifenacin or tolterodine. It is taken by mouth.

Chemical data

Formula
C21H24N4O2S
Molecular weight
396.5 g/mol
IUPAC name
2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide
SMILES
C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChIKey
PBAPPPCECJKMCM-IBGZPJMESA-N
XLogP
2.1
Polar surface area
129 Ų
H-bond donors
4
H-bond acceptors
6
Formal charge
0

via PubChem

Wikidata facts

Mass
396.162
Show 6 more facts
chemical formula
C₂₁H₂₄N₄O₂S
isomeric SMILES
C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
canonical SMILES
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
World Health Organisation international non-proprietary name
mirabegron
defined daily dose
50
Commons category
Mirabegron
Sources (7)

via Wikidata · CC0

~5 min read

Article

5 sections
Contents
  • Medical uses
  • Adverse effects
  • Research
  • References
  • Further reading

{{Drugbox | image = Mirabegron.svg | image_class = skin-invert-image | width = 300 | alt =

| tradename = Myrbetriq, Betanis, Betmiga, others | Drugs.com = | MedlinePlus = a612038 | DailyMedID = Mirabegron | pregnancy_AU = B3 | pregnancy_category = | routes_of_administration = By mouth | ATC_prefix = G04 | ATC_suffix = BD12

Connections

Categories